Arachidonic acid + Docosahexaenoic acid

Arachidonic acid (ARA) and docosahexaenoic acid (DHA) are long-chain polyunsaturated fatty acids that play crucial roles in human physiological processes. When used in combination, they have shown potential benefits for various conditions, particularly in infant development and neurological health. ARA is an omega-6 polyunsaturated fatty acid found abundantly in the brain, muscles, and liver[10]. DHA is an omega-3 fatty acid commonly found in cold-water fish like tuna and salmon[3]. Together, they represent a nutrient combination important for development, particularly in infants[7]. These fatty acids are vital components of cell membranes, especially in the brain, where they make up approximately 25% of the total fatty acid content[6]. They influence neuronal growth and differentiation through modulating membrane properties, signal transduction, and gene expression[6]. Research suggests that supplementation with ARA and DHA may improve impaired social interaction in individuals with autism spectrum disorders[1]. They also appear to have immunomodulatory effects, with studies showing they can modulate antigen-specific T cell responses[2]. Both fatty acids play neuroprotective roles against neurodegenerative conditions like Alzheimer's disease and Parkinson's disease, helping to combat mitochondrial dysfunction, neuroinflammation, and oxidative stress[6][9]. In infant nutrition, ARA and DHA are particularly important as infants have a limited ability to convert dietary fatty acids to ARA and DHA, making breast milk their only natural source. For non-breastfed infants, these nutrients are commonly added to infant formula products[7]. A recent study has developed a predigested product from ARA and DHA oils in a 2:1 ratio to improve bio-accessibility[4], suggesting ongoing research to enhance the delivery and efficacy of these fatty acids.

Other names

ARA + DHA